While every FSA and HSA program differs, many expire at the end of the year. Check the rules of your HSA or FSA to see if funds roll over to the next year. If funds do not roll over, you may have a limited time to spend those dollars. We have some ideas for HSA-eligible …
Weight Loss In 2023 Tirzepatide and semaglutide offer weight loss through weekly injections, however, as many scramble to obtain these medications, the supply chain has made this difficult. Semaglutide and tirzepatide have three main mechanisms of action. They enhance the growth of beta cells in the pancreas, which are sites of insulin production. This means …
What is Semaglutide? Semaglutide is a medication used to treat diabetes and obesity. It works by helping the body process insulin more easily, which in turn lowers blood sugar levels. This can help you feel full for longer periods. Semaglutide also helps retrain your brain to not feel compelled to clear your plate. The medication …
Everything You Need to Know Before You Start Semaglutide Read More »
Weight Loss Management Deciding you want to take steps towards losing weight is not always an easy decision. It’s a very personal one. Sometimes, you may look for ways to lose weight to avoid harmful words or negative stereotypes. Experiences like these can make weight loss management a stressful and self-conscious process, which isn’t ideal …
4 Critical Components for Weight Loss Management Read More »
Alternatives to Ozempic®and Wegovy® Semaglutide for weight loss has exploded in popularity since a landmark weight-loss trial in March of 2021. This medication is dispensed under the brand names Wegovy®and Ozepmic®, at over $900 and as high as $2000. Compounded semaglutide offers the same medication at a fraction of the cost with multiple advantages for …
Semaglutide From the start of the COVID-19 pandemic, obesity is apparent as a risk factor for severe COVID-19 illness. Recently, a study released by the Centers for Disease Control and Prevention (CDC) demonstrated just how nonlinear this relationship is. The vast majority (over 75%) of U.S. patients hospitalized with COVID-19 were overweight or had obesity. …
Semaglutide (GLP-1) and Low-Dose Naltrexone for Weight Loss Read More »
Copyright © 2021, Mobile Care | All Rights Reserved |
